A
Anke Bourgeois
Researcher at Institut de recherche pour le développement
Publications - 29
Citations - 1959
Anke Bourgeois is an academic researcher from Institut de recherche pour le développement. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 22, co-authored 29 publications receiving 1933 citations. Previous affiliations of Anke Bourgeois include University of Montpellier.
Papers
More filters
Journal ArticleDOI
Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial
Christian Laurent,Charles Kouanfack,Sinata Koulla-Shiro,Nathalie Nkoué,Anke Bourgeois,Alexandra Calmy,Bernadette Lactuock,Viviane Nzeusseu,Rose Mougnutou,Gilles Peytavin,Florian Liegeois,Eric Nerrienet,Michèle Tardy,Martine Peeters,Isabelle Andrieux-Meyer,Leopold Zekeng,Michel D. Kazatchkine,Eitel Mpoudi-Ngole,Eric Delaporte +18 more
TL;DR: The findings lend support to use and funding of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine as first-line antiretroviral treatment in developing countries.
Journal ArticleDOI
Genetic Diversity of Protease and Reverse Transcriptase Sequences in Non-Subtype-B Human Immunodeficiency Virus Type 1 Strains: Evidence of Many Minor Drug Resistance Mutations in Treatment-Naive Patients
Laurence Vergne,Martine Peeters,Eitel Mpoudi-Ngole,Anke Bourgeois,Florian Liegeois,Coumba Toure-Kane,Souleymane Mboup,Claire Mulanga-Kabeya,Eric Saman,Jacques Jourdan,Jacques Reynes,Eric Delaporte +11 more
TL;DR: Phenotypic and clinical studies are now required to determine whether multidrug-resistant viruses emerge more rapidly during antiretroviral therapy when minor resistance-conferring mutations are present before treatment initiation.
Journal ArticleDOI
Characterization of a Highly Replicative Intergroup M/O Human Immunodeficiency Virus Type 1 Recombinant Isolated from a Cameroonian Patient
Martine Peeters,Florian Liegeois,Ndongo Torimiro,Anke Bourgeois,Eitel N. Mpoudi,Laurence Vergne,Eric Saman,Eric Delaporte,Sentob Saragosti +8 more
TL;DR: For the first time a recombination event in vivo between viruses belonging to two different groups, leading to a replicative virus is described, which will have important implications for diagnosis of HIV-1 infections by serological and molecular tests, as well as for antiviral treatment.
Journal ArticleDOI
Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG.
Celine Montavon,Coumba Toure-Kane,Florian Liegeois,Eitel N. Mpoudi,Anke Bourgeois,Laurence Vergne,Jean-Luc Perret,Annie Boumah,Eric Saman,Souleymane Mboup,Eric Delaporte,Martine Peeters +11 more
TL;DR: Data suggest that in West Africa, most probably between 60% and 84% of the subtype A viruses are recombinant AG-IBNG viruses, which has potential implications on future vaccine, diagnostic, and treatment strategies.
Journal ArticleDOI
Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K.
Karine Triques,Anke Bourgeois,Nicole Vidal,Eitel Mpoudi-Ngole,Claire Mulanga-Kabeya,Nzila Nzilambi,Ndongo Torimiro,Eric Saman,Eric Delaporte,Martine Peeters +9 more
TL;DR: The equidistance of subtype K to the other subtypes of HIV-1 suggests that this subtype existed as long as the others, the lower distance between B and D, and between F1 and F2 suggest a more recent subdivision for these latter strains.